Company Data
Outlook Therapeutics Inc.
Ticker
OTLK
Current Price
$1.56 -4.88%
Market Cap
$49.9M
Price Target
Refer to Report
Volume
753.1K
52wk Range
$0.87 - $12.8499
Overview
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.